{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:56:29Z","timestamp":1759366589874,"version":"build-2065373602"},"reference-count":6,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,5]],"date-time":"2021-02-05T00:00:00Z","timestamp":1612483200000},"content-version":"vor","delay-in-days":493,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Indian Journal of Medical Microbiology"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.4103\/ijmm.ijmm_20_142","type":"journal-article","created":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T04:18:46Z","timestamp":1589775526000},"page":"600-601","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Will the Recently Reinstated CLSI 2020 Breakpoints of Norfloxacin for Urinary Isolates Work for India? \u2013 Tertiary Care Experience and Evidence"],"prefix":"10.1016","volume":"37","author":[{"given":"Rani Diana","family":"Sahni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Balaji","family":"Veeraraghavan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dhiviya","family":"Prabaa MS","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jobin John","family":"Jacob","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2020","series-title":"Performance Standards for Antimicrobial Susceptibility Testing. CLSI Supplement M100","key":"10.4103\/ijmm.IJMM_20_142_bib1"},{"key":"10.4103\/ijmm.IJMM_20_142_bib2","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1128\/AAC.50.4.1528-1530.2006","article-title":"Microflora changes with norfloxacin and pivmecillinam in women with recurrent urinary tract infection","volume":"50","author":"Norinder","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.4103\/ijmm.IJMM_20_142_bib3","doi-asserted-by":"crossref","first-page":"e02072-18","DOI":"10.1128\/JCM.02072-18","article-title":"Don\u2019t get wound up: Revised fluoroquinolone breakpoints for Enterobacteriaceae and Pseudomonas aeruginosa","volume":"57","author":"Van","year":"2019","journal-title":"J Clin Microbiol"},{"key":"10.4103\/ijmm.IJMM_20_142_bib4","doi-asserted-by":"crossref","first-page":"e0190729","DOI":"10.1371\/journal.pone.0190729","article-title":"Analytical profiling of mutations in quinolone resistance determining region of gyrA gene among UPEC","volume":"13","author":"Varughese","year":"2018","journal-title":"PLoS One"},{"key":"10.4103\/ijmm.IJMM_20_142_bib5","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/s13104-015-1200-2","article-title":"Antimicrobial resistance profile of Enterococcus species isolated from intestinal tracts of hospitalized patients in Jimma, Ethiopia","volume":"8","author":"Abamecha","year":"2015","journal-title":"BMC Res Notes"},{"key":"10.4103\/ijmm.IJMM_20_142_bib6","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1046\/j.1469-0691.2002.00400.x","article-title":"Correlation between the activity of different fluoroquinolones and the presence of mechanisms of quinolone resistance in epidemiologically related and unrelated strains of methicillin-susceptible and -resistant Staphylococcus aureus","volume":"8","author":"Sierra","year":"2002","journal-title":"Clin Microbiol Infect"}],"container-title":["Indian Journal of Medical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0255085720313517?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0255085720313517?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T19:18:04Z","timestamp":1759346284000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0255085720313517"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":6,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S0255085720313517"],"URL":"https:\/\/doi.org\/10.4103\/ijmm.ijmm_20_142","relation":{},"ISSN":["0255-0857"],"issn-type":[{"type":"print","value":"0255-0857"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Will the Recently Reinstated CLSI 2020 Breakpoints of Norfloxacin for Urinary Isolates Work for India? \u2013 Tertiary Care Experience and Evidence","name":"articletitle","label":"Article Title"},{"value":"Indian Journal of Medical Microbiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4103\/ijmm.IJMM_20_142","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2019 Indian Journal of Medical Microbiology. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}